Search tips
Search criteria 


Logo of bmjThe BMJ
BMJ. 1996 February 3; 312(7026): 273–276.
PMCID: PMC2349888

Neglected aspects of false positive findings of mammography in breast cancer screening: analysis of false positive cases from the Stockholm trial.


OBJECTIVES: To examine the implications of false positive results of mammography in terms of the time lag from screening and complete mammography to the point when women with false positive results are declared free of cancer; the extra examinations, biopsies, and check ups required; and the cost of these extra procedures. DESIGN: Review of women with false positive results from the Stockholm mammography screening trial. SETTING: Department of Oncology, South Hospital, Stockholm. SUBJECTS: 352 and 150 women with false positive results of mammography from the first and second screening rounds of the Stockholm trial. MAIN OUTCOME MEASURES: Extra examinations and investigations required and the cost of these procedures. RESULTS: The 352 women from the first screening round made 1112 visits to the physician and had 397 fine needle aspiration biopsies, 187 mammograms, and 90 surgical biopsies before being declared free of cancer. After six months 64% of the women (219/342) were declared cancer free. The 150 women in the second round made 427 visits to the physician and had 145 fine needle aspiration biopsies, 70 mammograms, and 28 surgical biopsies, and after six months 73% (107/147) were declared cancer free. The follow up costs of the false positive screening results were Kr2.54m (250,000 pounds) in the first round and Kr0.85m (84,000 pounds) in the second round. Women under 50 accounted for about 41% of these costs. CONCLUSIONS: The examinations and investigation carried out after false positive mammography --especially in women under 50--and the cost of these procedures are a neglected but substantial problem.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (849K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Nyström L, Rutqvist LE, Wall S, Lindgren A, Lindqvist M, Rydén S, Andersson I, Bjurstam N, Fagerberg G, Frisell J, et al. Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet. 1993 Apr 17;341(8851):973–978. [PubMed]
  • Shapiro S, Venet W, Strax P, Venet L, Roeser R. Ten- to fourteen-year effect of screening on breast cancer mortality. J Natl Cancer Inst. 1982 Aug;69(2):349–355. [PubMed]
  • Tabár L, Fagerberg CJ, Gad A, Baldetorp L, Holmberg LH, Gröntoft O, Ljungquist U, Lundström B, Månson JC, Eklund G, et al. Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet. 1985 Apr 13;1(8433):829–832. [PubMed]
  • Wright CJ. Breast cancer screening: a different look at the evidence. Surgery. 1986 Oct;100(4):594–598. [PubMed]
  • Eddy DM, Hasselblad V, McGivney W, Hendee W. The value of mammography screening in women under age 50 years. JAMA. 1988 Mar 11;259(10):1512–1519. [PubMed]
  • Devitt JE. False alarms of breast cancer. Lancet. 1989 Nov 25;2(8674):1257–1258. [PubMed]
  • Andersson I, Janzon L, Pettersson H. Radiographic patterns of the mammary parenchyma: variation with age at examination and age at first birth. Radiology. 1981 Jan;138(1):59–62. [PubMed]
  • Gram IT, Lund E, Slenker SE. Quality of life following a false positive mammogram. Br J Cancer. 1990 Dec;62(6):1018–1022. [PMC free article] [PubMed]
  • Lerman CE, Rimer BK. Psychosocial impact of cancer screening. Oncology (Williston Park) 1993 Apr;7(4):67–79. [PubMed]
  • Cockburn J, De Luise T, Hurley S, Clover K. Development and validation of the PCQ: a questionnaire to measure the psychological consequences of screening mammography. Soc Sci Med. 1992 May;34(10):1129–1134. [PubMed]
  • Skrabanek P. The cost-effectiveness of breast cancer screening. Int J Technol Assess Health Care. 1991;7(4):633–635. [PubMed]
  • Brown ML. Economic considerations in breast cancer screening of older women. J Gerontol. 1992 Nov;47(Spec No):51–58. [PubMed]
  • Elixhauser A. Costs of breast cancer and the cost-effectiveness of breast cancer screening. Int J Technol Assess Health Care. 1991;7(4):604–615. [PubMed]
  • Mushlin AI, Fintor L. Is screening for breast cancer cost-effective? Cancer. 1992 Apr 1;69(7 Suppl):1957–1962. [PubMed]
  • Okubo I, Glick H, Frumkin H, Eisenberg JM. Cost-effectiveness analysis of mass screening for breast cancer in Japan. Cancer. 1991 Apr 15;67(8):2021–2029. [PubMed]
  • Miller AB. The costs and benefits of breast cancer screening. Am J Prev Med. 1993 May-Jun;9(3):175–180. [PubMed]
  • Erichsen GG. Mammeografisk screening for cancer mammae--en cost-benefit analyse. Nord Med. 1990;105(2):64–66. [PubMed]
  • Brown ML. Sensitivity analysis in the cost-effectiveness of breast cancer screening. Cancer. 1992 Apr 1;69(7 Suppl):1963–1967. [PubMed]
  • van der Maas PJ, de Koning HJ, van Ineveld BM, van Oortmarssen GJ, Habbema JD, Lubbe KT, Geerts AT, Collette HJ, Verbeek AL, Hendriks JH, et al. The cost-effectiveness of breast cancer screening. Int J Cancer. 1989 Jun 15;43(6):1055–1060. [PubMed]
  • de Koning HJ, van Ineveld BM, van Oortmarssen GJ, de Haes JC, Collette HJ, Hendriks JH, van der Maas PJ. Breast cancer screening and cost-effectiveness; policy alternatives, quality of life considerations and the possible impact of uncertain factors. Int J Cancer. 1991 Oct 21;49(4):531–537. [PubMed]
  • Shapiro S, Strax P, Venet L. Periodic breast cancer screening in reducing mortality from breast cancer. JAMA. 1971 Mar 15;215(11):1777–1785. [PubMed]
  • Tabàr L, Gad A. Screening for breast cancer: the Swedish trial. Radiology. 1981 Jan;138(1):219–222. [PubMed]
  • Andersson I, Aspegren K, Janzon L, Landberg T, Lindholm K, Linell F, Ljungberg O, Ranstam J, Sigfússon B. Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial. BMJ. 1988 Oct 15;297(6654):943–948. [PMC free article] [PubMed]
  • Frisell J, Eklund G, Hellström L, Glas U, Somell A. The Stockholm breast cancer screening trial--5-year results and stage at discovery. Breast Cancer Res Treat. 1989 Jan;13(1):79–87. [PubMed]
  • Frisell J, Glas U, Hellström L, Somell A. Randomized mammographic screening for breast cancer in Stockholm. Design, first round results and comparisons. Breast Cancer Res Treat. 1986;8(1):45–54. [PubMed]
  • Tabàr L, Fagerberg G, Duffy SW, Day NE, Gad A, Gröntoft O. Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clin North Am. 1992 Jan;30(1):187–210. [PubMed]
  • McLelland R, Pisano ED. The politics of mammography. Radiol Clin North Am. 1992 Jan;30(1):235–241. [PubMed]
  • Fentiman IS. Pensive women, painful vigils: consequences of delay in assessment of mammographic abnormalities. Lancet. 1988 May 7;1(8593):1041–1042. [PubMed]
  • Frisell J, Eklund G, Hellström L, Lidbrink E, Rutqvist LE, Somell A. Randomized study of mammography screening--preliminary report on mortality in the Stockholm trial. Breast Cancer Res Treat. 1991 Mar;18(1):49–56. [PubMed]
  • Lidbrink EK, Törnberg SA, Azavedo EM, Frisell JO, Hjalmar ML, Leifland KS, Sahlstedt TB, Skoog L. The general mammography screening program in Stockholm. Organisation and first-round results. Acta Oncol. 1994;33(4):353–358. [PubMed]

Articles from The BMJ are provided here courtesy of BMJ Publishing Group